Literature DB >> 6256410

Simultaneous assay of immunoreactive beta-lipotropin, gamma-lipotropin, and beta-endorphin in plasma of normal human subjects, patients with ACTH/lipotropin hypersecretory syndromes, and patients undergoing chronic hemodialysis.

X Y Bertagna, W J Stone, W E Nicholson, C D Mount, D N Orth.   

Abstract

We have studied the relative concentrations of the human immunoreactive (IR) peptides gamma-lipotropin (hgammaLPH, [1-58]hbetaLPH), beta-lipotropin (hbetaLPH), and beta-endorphin (hbetaEND, [61-91]hbetaLPH) using gel exclusion chromatography together with a specific radio-immunoassay (RIA) for hgammaLPH and a RIA that (because hbetaEND is the COOH-terminus of the hbetaLPH molecule) measures both hbetaEND and hbetaLPH on an equimolar basis. In normal subjects, basal plasma IR-hgammaLPH was often undetectable (<12.5 fmol/ml), but ranged up to 21 fmol/ml, and IR-hbetaEND/hbetaLPH was 10.8+/-0.7 fmol/ml; previous studies by others suggest that most of the IR-hbetaEND/hbetaLPH was probably hbetaLPH. Both IR-hgammaLPH and IR-hbetaEND/hbetaLPH were significantly elevated (P < 0.001) in patients undergoing chronic hemodialysis (101.5+/-12.7 and 23.8+/-2.0 fmol/ml, respectively). Their IR-hgammaLPH coeluted with standard hgammaLPH as a single peak, and IR-hbetaEND/hbetaLPH coeluted with hbetaLPH; no distinct peak of IR-hbetaEND was observed. In patients with ACTH/LPH hypersecretion due to Addison's disease, Nelson's syndrome, or ectopic ACTH syndrome, IR-hgammaLPH and IR-hbetaEND/hbetaLPH were both elevated, and IR-hbetaEND/hbetaLPH eluted as two peaks, one coeluting with hbetaLPH and the other with hbetaEND. The molar concentrations of all three peptides were significantly correlated with one another. The lower concentrations of endogenous IR-hbetaEND observed may be due in part to its apparent shorter plasma half-life, as estimated in an Addison's patient given a cortisol infusion. The biologic significance of these three peptides in circulating blood is still unknown. The increased levels of hbetaLPH and hgammaLPH in plasma of patients with chronic renal failure suggest that the kidney may be an important organ for their metabolism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6256410      PMCID: PMC371579          DOI: 10.1172/JCI110004

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  B-ETA-Endorphin immunoreactivity in rat and human blood: radioimmunoassay, comparative levels and physiological alterations.

Authors:  H Akil; S J Watson; J D Barchas; C H Li
Journal:  Life Sci       Date:  1979-04-30       Impact factor: 5.037

2.  Primary structure of human beta-lipotropin.

Authors:  C H Li; D Chung
Journal:  Nature       Date:  1976-04-15       Impact factor: 49.962

3.  Isolation of peptides with opiate activity from sheep and human pituitaries: relationship to beta-lipotropin.

Authors:  M Chrétien; S Benjannet; N Dragon; N G Seidah; M Lis
Journal:  Biochem Biophys Res Commun       Date:  1976-09-20       Impact factor: 3.575

4.  Dynamics and characterization of plasma immunoreactive beta-melanocyte stimulating hormone in hemodialysis patients: its relationship to ACTH.

Authors:  X Bertagna; M Donnadieu; J M Idatte; F Girard
Journal:  J Clin Endocrinol Metab       Date:  1977-12       Impact factor: 5.958

5.  beta-Endorphin is not detectable in plasma from normal human subjects.

Authors:  T Suda; A S Liotta; D T Krieger
Journal:  Science       Date:  1978-10-13       Impact factor: 47.728

6.  Development and validation of a radioimmunoassay for peptides related to beta-melanocyte-stimulating hormone in human plasma: the lipotropins.

Authors:  J J Gilkes; G A Bloomfield; A P Scott; P J Lowry; J G Ratcliffe; J Landon; L H Rees
Journal:  J Clin Endocrinol Metab       Date:  1975-03       Impact factor: 5.958

7.  Characterization of lipotropin-, corticotropin-, and beta-endorphin-immunoreactive materials secreted in vitro by a human pituitary adenoma responsible for a case of Nelson's syndrome.

Authors:  X Bertagna; J P Luton; M Binoux; H Bricaire; F Girard
Journal:  J Clin Endocrinol Metab       Date:  1979-10       Impact factor: 5.958

8.  The nature of the immunoreactive lipotropins in human plasma and tissue extracts.

Authors:  K Tanaka; W E Nicholson; D N Orth
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

Review 9.  Clinical significance of circulating proinsulin and C-peptide.

Authors:  A H Rubenstein; D F Steiner; D L Horwitz; M E Mako; M B Block; J I Starr; H Kuzuya; F Melani
Journal:  Recent Prog Horm Res       Date:  1976

10.  Pituitary and plasma lipotropins: demonstration of the artificial nature of betaMSH.

Authors:  I Bachelot; A R Wolfsen; W D Odell
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

View more
  6 in total

1.  Endogenous ACTH concentration-cortisol secretion dose analysis unmasks decreased ACTH potency in Cushing's disease with restoration after successful pituitary adenomectomy.

Authors:  Ferdinand Roelfsema; Daniel M Keenan; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2011-09-14       Impact factor: 5.958

2.  Pituitary-like proopiomelanocortin transcripts in human Leydig cell tumors.

Authors:  Y de Keyzer; F Lenne; J F Massias; D Vieau; J P Luton; A Kahn; X Bertagna
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

3.  NH2-terminal amino acid sequence and peptide mapping of purified human beta-lipotropin: comparison with previously proposed sequences.

Authors:  J Spiess; C D Mount; W E Nicholson; D N Orth
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

4.  Plasma pro-opiomelanocortin fragments and adrenal steroids following administration of metyrapone to normal and hirsute women.

Authors:  S K Cunningham; T Loughlin; X Bertagna; F Girard; T J McKenna
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

5.  Beta-endorphin inhibits glucose production in the conscious dog.

Authors:  P M Radosevich; P E Williams; J R McRae; W W Lacy; D N Orth; N N Abumrad
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

6.  Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries.

Authors:  Y de Keyzer; X Bertagna; F Lenne; F Girard; J P Luton; A Kahn
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.